These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9309521)

  • 21. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
    Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors of respiratory failure in children with Guillain-Barré syndrome.
    Hu MH; Chen CM; Lin KL; Wang HS; Hsia SH; Chou ML; Hung PC; Wu CT
    Pediatr Neonatol; 2012 Oct; 53(5):295-9. PubMed ID: 23084721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of Guillain-Barré syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India.
    Kishore CK; Vijayabhaskar J; Vishnu Vardhan R; Sainaresh VV; Sriramnaveen P; Sridhar AV; Varalaxmi B; Sandeep P; Ram R; Vengamma B; Siva Kumar V
    Ren Fail; 2014 Jun; 36(5):732-6. PubMed ID: 24593239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of immunomodulation therapies in mechanically ventilated patients with Guillain Barré syndrome.
    Netto AB; Kulkarni GB; Taly AB; Rao GU; Periyavan S; Rao S
    J Clin Neurosci; 2012 Dec; 19(12):1664-7. PubMed ID: 23036171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
    Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with Guillain-Barré syndrome in a neurological Intensive Care Unit.
    González P; García X; Guerra A; Arango JC; Delgado H; Uribe CS; Sará J; López de Mesa JC; Hernández O
    Neurologia; 2016; 31(6):389-94. PubMed ID: 25542501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of intravenous immunoglobulins in Guillain-Barré syndrome].
    Ceccarelli M; Assanta N; Chiaravalloti G; Rocopou C; Caiulo VA
    Minerva Pediatr; 1992 May; 44(5):237-40. PubMed ID: 1620076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study.
    El-Bayoumi MA; El-Refaey AM; Abdelkader AM; El-Assmy MM; Alwakeel AA; El-Tahan HM
    Crit Care; 2011 Jul; 15(4):R164. PubMed ID: 21745374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seasonal variation in the clinical recovery of patients with Guillain Barré syndrome requiring mechanical ventilation.
    Sriganesh K; Netto A; Kulkarni GB; Taly AB; Umamaheswara Rao GS
    Neurol India; 2013; 61(4):349-54. PubMed ID: 24005723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second response to immunoglobulin in recurrent Guillain-Barré syndrome.
    Nagappan R; Barker J
    N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fluctuations in Guillain-Barré syndrome related with intravenous human immunoglobulin (triphasic course): case report].
    Dourado ME; De Freitas ML; Dos Santos FM
    Arq Neuropsiquiatr; 1998 Sep; 56(3A):476-9. PubMed ID: 9754432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of immunoglobulin in severe childhood Guillain-Barré syndrome.
    Ortiz-Corredor F; Peña-Preciado M
    Acta Neurol Scand; 2007 Apr; 115(4):289-93. PubMed ID: 17376129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous immunoglobulin in two children with Guillain-Barré syndrome.
    Notarangelo LD; Duse M; Tiberti S; Guarneri B; Brunori A; Negrini A; Ugazio AG
    Eur J Pediatr; 1993 Apr; 152(4):372-4. PubMed ID: 8482293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barré syndrome.
    Charra B; Hachimi A; Benslama A; Motaouakkil S
    Pan Afr Med J; 2014; 18():35. PubMed ID: 25368724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group.
    Ann Neurol; 1994 Jun; 35(6):749-52. PubMed ID: 8210234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
    Nobile-Orazio E; Bersano A
    Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk factors of respiratory failure in children with Guillain-Barré syndrome.
    Rantala H; Uhari M; Cherry JD; Shields WD
    Pediatr Neurol; 1995 Nov; 13(4):289-92. PubMed ID: 8771163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management and outcome of severe Guillain-Barré syndrome.
    Ng KK; Howard RS; Fish DR; Hirsch NP; Wiles CM; Murray NM; Miller DH
    QJM; 1995 Apr; 88(4):243-50. PubMed ID: 7796073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Intravenous immunoglobulin treatment in childhood Guillain-Barré syndrome'.
    Manonmani V; Ouvrier R
    Dev Med Child Neurol; 1997 Jun; 39(6):425. PubMed ID: 9233371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.